Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2020 Financial Results
MALVERN, Pa., Jan. 12, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on
Read moreUS64131A1051
Neuronetics to Participate at the 23rd Annual ICR Westwicke Conference
MALVERN, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,
Read moreNeuronetics Announces Expansion of Sales Organization
MALVERN, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on
Read moreNeuronetics Announces the Amendment of Credit Facility with Solar Capital Partners
Amendment provides Neuronetics with available and flexible funding options through 2022 MALVERN, Pa., Dec. 08, 2020 (GLOBE NEWSWIRE) — Neuronetics,
Read moreNeuronetics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
MALVERN, Pa., Nov. 30, 2020 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,
Read moreNeuronetics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
MALVERN, Pa., Nov. 30, 2020 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,
Read moreNeuronetics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
MALVERN, Pa., Nov. 30, 2020 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,
Read moreNeuronetics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
MALVERN, Pa., Nov. 30, 2020 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,
Read moreNeuronetics® Receives FDA Clearance for Three-Minute TouchStar™ Treatment Protocol
TouchStar theta burst protocol leverages NeuroStar® Advanced Therapy’s patented Contact Sensing technology to help ensure the optimum prescribed treatment dose
Read moreNeuronetics to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
MALVERN, Pa., Nov. 12, 2020 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,
Read more